We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Acxiom & Thunder Team Up to Bring Precision in Targeting Ads
Read MoreHide Full Article
In a bid to deliver people-based marketing, Acxiom Corporation’s unit LiveRamp recently partnered Thunder Experience Cloud. Notably, this individual-based initiative is a significant improvement over cookie-based marketing.
The companies have collaborated to enhance advertising to target people better with a calculated and customized methodology.
LiveRamp’s IdentityLink service will enable customers to get a comprehensive profile of the consumer leveraging data from both offline and digital platforms. Meanwhile, Thunder provides people-based ad server where users can personalize and measure ads on a dynamic basis.
The fact that the two platforms complement each other enables the marketers to create ads with precision, as they leverage people-based IDs compliant with data privacy regulations.
The new initiative is a significant improvement over the traditional methods of using Cookie IDs or various “third party measurement” platforms which might not be secure.
The consumers will also benefit from more relatable engagement from brands, consequently aiding them in search of required solutions.
In the words of Paul Turner, GM of Technology at LiveRamp, “This partnership is truly changing the standards of measurement and relevance in advertising.”
Targeting an Individual over the Entire Family
The shared IP addresses aided Thunder to determine whether a smartphone, tablet, or laptop was owned by a same group of individuals. LiveRamp’s identity graph having around 300 million profiles globally is enabling Thunder’s Experience Cloud to assess if the device is owned by the same entity.
The partnership is a win-win situation for both the companies in the sense that Thunder will be able to zero in on “individual” marketing over “family or household” based ads.
What Investors Should Know
Talking about share price performance, Acxiom’s stock has returned 80.7% year to date, outperforming the industry’s rally of 15.8%. The stock has also fared better than the S&P 500 index’s rise of 10.3%.
The outperformance can primarily be attributed to the company’s initiatives to enhance LiveRamp platform. Further, the divestiture of Acxiom Marketing Solutions (“AMS”) business to Interpublic Group (IPG - Free Report) has kept the investors optimistic.
The increasing use of smartphones and internet has fueled the demand for digital advertising. Per eMarketer report, the digital ad spending is expected to reach $273.29 billion in 2018 and $357.31 billion by 2020 from $232.27 billion in 2017.
Per Reportbuyer data, the contextual advertising market is projected to reach $328.1 billion by 2024 at a CAGR of 17.4% over 2017. Notably, contextual advertising includes location and activity-based tracking of consumer data build around online browsing history.
We believe this partnership will bolster adoption of LiveRamp services. Further, Acxiom’s frequent product innovations and partnerships are anticipated to enhance location-based targeting platforms for digital campaigns, consequently boosting the company’s top-line.
Salesforce and KLA-Tencor have a long-term earnings growth rate of 25% and 9.8%, respectively.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits. Click here to see the 5 stocks >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Acxiom & Thunder Team Up to Bring Precision in Targeting Ads
In a bid to deliver people-based marketing, Acxiom Corporation’s unit LiveRamp recently partnered Thunder Experience Cloud. Notably, this individual-based initiative is a significant improvement over cookie-based marketing.
The companies have collaborated to enhance advertising to target people better with a calculated and customized methodology.
LiveRamp’s IdentityLink service will enable customers to get a comprehensive profile of the consumer leveraging data from both offline and digital platforms. Meanwhile, Thunder provides people-based ad server where users can personalize and measure ads on a dynamic basis.
The fact that the two platforms complement each other enables the marketers to create ads with precision, as they leverage people-based IDs compliant with data privacy regulations.
The new initiative is a significant improvement over the traditional methods of using Cookie IDs or various “third party measurement” platforms which might not be secure.
The consumers will also benefit from more relatable engagement from brands, consequently aiding them in search of required solutions.
In the words of Paul Turner, GM of Technology at LiveRamp, “This partnership is truly changing the standards of measurement and relevance in advertising.”
Targeting an Individual over the Entire Family
The shared IP addresses aided Thunder to determine whether a smartphone, tablet, or laptop was owned by a same group of individuals. LiveRamp’s identity graph having around 300 million profiles globally is enabling Thunder’s Experience Cloud to assess if the device is owned by the same entity.
The partnership is a win-win situation for both the companies in the sense that Thunder will be able to zero in on “individual” marketing over “family or household” based ads.
What Investors Should Know
Talking about share price performance, Acxiom’s stock has returned 80.7% year to date, outperforming the industry’s rally of 15.8%. The stock has also fared better than the S&P 500 index’s rise of 10.3%.
The outperformance can primarily be attributed to the company’s initiatives to enhance LiveRamp platform. Further, the divestiture of Acxiom Marketing Solutions (“AMS”) business to Interpublic Group (IPG - Free Report) has kept the investors optimistic.
The increasing use of smartphones and internet has fueled the demand for digital advertising. Per eMarketer report, the digital ad spending is expected to reach $273.29 billion in 2018 and $357.31 billion by 2020 from $232.27 billion in 2017.
Per Reportbuyer data, the contextual advertising market is projected to reach $328.1 billion by 2024 at a CAGR of 17.4% over 2017. Notably, contextual advertising includes location and activity-based tracking of consumer data build around online browsing history.
We believe this partnership will bolster adoption of LiveRamp services. Further, Acxiom’s frequent product innovations and partnerships are anticipated to enhance location-based targeting platforms for digital campaigns, consequently boosting the company’s top-line.
Zacks Rank & Key Picks
Acxiom carries a Zacks Rank #3 (Hold).
Salesforce.com Inc (CRM - Free Report) and KLA-Tencor Corporation (KLAC - Free Report) are a couple of stocks worth considering, in the same sector. Both the stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Salesforce and KLA-Tencor have a long-term earnings growth rate of 25% and 9.8%, respectively.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>